Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional
Johnson & Johnson and Crucell N.V. today announce that Johnson & Johnson has completed the tender offer for Crucell N.V. and has declared the offer unconditional. Â As a result, Crucell will now operate as the center for vaccines within the Johnson & Johnson pharmaceuticals group.
